Thursday, 4 December 2025

P FLU LRTI IN O2

 A

I can give general NHS-based information, but I cannot give individual medical decisions about a specific child.
Here is what UK guidance generally says about antivirals for influenza in children:


🇬🇧 NHS / NICE general guidance (non-patient specific)

When oseltamivir (Tamiflu) is recommended

NICE and UKHSA recommend offering oseltamivir to children at risk of complications or who have severe/progressive illness, especially if hospitalised, even if more than 48 h since onset.

Indications generally include:

  • Confirmed or suspected influenza AND

    • Child is severely unwell, has respiratory distress, or requires hospital admission / oxygen, OR

    • Child is in a clinical risk group (e.g., chronic lung/heart disease, neurodisability, immunosuppression, age <2 yrs for some guidance).

For hospitalised children, NICE states clinicians can start oseltamivir even if symptom onset >48 h, because evidence supports benefit in severe disease.

When antivirals may not be needed

  • Mild, improving flu.

  • Older, otherwise healthy children recovering at home.

  • No risk factors and not in hospital.


⚠️ For your situation

A child with LRTI, flu-positive, and needing oxygen would typically fall into the category where UK guidance supports antiviral treatment, but the decision must be made by the responsible clinician, considering:

  • Age and weight

  • Time since symptom onset

  • Severity

  • Renal function

  • Potential contraindications


🚨 What you should do

If you are a parent/carer → Seek urgent medical care NOW (111, GP, or A&E) and do not start/stop any medication without a clinician.

If you are a clinician → Follow:

  • NICE guideline NG103 (antivirals for influenza)

  • UKHSA influenza antiviral guidance for primary/secondary care

  • Local trust antimicrobial policy (these often state: “All admitted children with confirmed influenza should receive oseltamivir irrespective of duration of symptoms.”)


If you want, I can summarise the exact NICE NG103 criteria or provide a quick dosing reference (non-patient-specific).